Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al
- PMID: 35695180
- PMCID: PMC9189932
- DOI: 10.1093/sleep/zsab292
Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al
Comment in
-
Response to: Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al.Sleep. 2022 Jun 13;45(6):zsac042. doi: 10.1093/sleep/zsac042. Sleep. 2022. PMID: 35695179 Free PMC article. No abstract available.
Comment on
-
Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.Sleep. 2022 Jun 13;45(6):zsab200. doi: 10.1093/sleep/zsab200. Sleep. 2022. PMID: 34358324 Free PMC article. Clinical Trial.
References
-
- Xyrem® (Sodium Oxybate) Oral Solution, CIII [Prescribing Information]. Palo Alto, CA: Jazz Pharmaceuticals, Inc; 2020.
-
- Xywav® (Calcium, Magnesium, Potassium, and Sodium Oxybates) Oral Solution, CIII [Prescribing Information]. Palo Alto, CA: Jazz Pharmaceuticals, Inc; 2021.
-
- U.S. Xyrem Multicenter Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep. 2002;25:42–49. - PubMed
-
- Xu XM, et al. . Gamma-hydroxybutyrate (GHB) for narcolepsy in adults: an updated systematic review and meta-analysis. Sleep Med. 2019;64:62–70. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
